1. Home
  2. NXPL vs COCP Comparison

NXPL vs COCP Comparison

Compare NXPL & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • COCP
  • Stock Information
  • Founded
  • NXPL 1997
  • COCP 2006
  • Country
  • NXPL United States
  • COCP United States
  • Employees
  • NXPL N/A
  • COCP N/A
  • Industry
  • NXPL Telecommunications Equipment
  • COCP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPL Telecommunications
  • COCP Health Care
  • Exchange
  • NXPL Nasdaq
  • COCP Nasdaq
  • Market Cap
  • NXPL 17.9M
  • COCP 15.4M
  • IPO Year
  • NXPL N/A
  • COCP N/A
  • Fundamental
  • Price
  • NXPL $0.76
  • COCP $1.60
  • Analyst Decision
  • NXPL
  • COCP Strong Buy
  • Analyst Count
  • NXPL 0
  • COCP 1
  • Target Price
  • NXPL N/A
  • COCP $6.00
  • AVG Volume (30 Days)
  • NXPL 62.7K
  • COCP 26.7K
  • Earning Date
  • NXPL 08-13-2025
  • COCP 08-13-2025
  • Dividend Yield
  • NXPL N/A
  • COCP N/A
  • EPS Growth
  • NXPL N/A
  • COCP N/A
  • EPS
  • NXPL N/A
  • COCP N/A
  • Revenue
  • NXPL $62,515,000.00
  • COCP N/A
  • Revenue This Year
  • NXPL N/A
  • COCP N/A
  • Revenue Next Year
  • NXPL N/A
  • COCP N/A
  • P/E Ratio
  • NXPL N/A
  • COCP N/A
  • Revenue Growth
  • NXPL 19.36
  • COCP N/A
  • 52 Week Low
  • NXPL $0.43
  • COCP $1.12
  • 52 Week High
  • NXPL $2.30
  • COCP $3.26
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 49.77
  • COCP 49.83
  • Support Level
  • NXPL $0.75
  • COCP $1.59
  • Resistance Level
  • NXPL $0.94
  • COCP $1.68
  • Average True Range (ATR)
  • NXPL 0.07
  • COCP 0.12
  • MACD
  • NXPL -0.00
  • COCP -0.01
  • Stochastic Oscillator
  • NXPL 18.18
  • COCP 28.57

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: